Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate.

Harrington, R D; Woodward, J A; Hooton, T M; Horn, J R

Harrington, R D; Woodward, J A; Hooton, T M; Horn, J R.

Affiliation

Harrington RD; Department of Medicine, School of Medicine, University of Washington, Seattle, USA. rdh@u.washington.edu

Arch Intern Med ; 159(18): 2221-4, 1999 Oct 11.

Article in En | MEDLINE | ID: mdl-10527300

Subject(s)

Acquired Immunodeficiency Syndrome/drug therapy; Adrenergic Uptake Inhibitors/adverse effects; Anesthetics/adverse effects; HIV Protease Inhibitors/pharmacology; Hallucinogens/adverse effects; N-Methyl-3,4-methylenedioxyamphetamine/adverse effects; Ritonavir/pharmacology; Saquinavir/pharmacology; Sodium Oxybate/adverse effects; Adult; Drug Synergism; Humans; Male

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sodium Oxybate / Acquired Immunodeficiency Syndrome / HIV Protease Inhibitors / N-Methyl-3,4-methylenedioxyamphetamine / Adrenergic Uptake Inhibitors / Ritonavir / Saquinavir / Hallucinogens / Anesthetics Limits: Adult / Humans / Male Language: En Journal: Arch Intern Med Year: 1999 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links